Intermediate Risk References

#1

Bahn, D
Targeted Cryoablation of the Prostate: 7_Year Outcomes in the Primary Treatment of Prostate Cancer

Urology 2002;60(2A):3-11

Find this article


#23

Bittner, N
Primary causes of death after permanent prostate brachytherapy

IJROBP 2008;72(2):433-440

Find this article


#24

Bittner, N
Primary causes of death after permanent prostate brachytherapy

IJROBP 2008;72(2):433-440

Find this article


#2

Boorjian,S
Mayo Clinic Validation of the D'Amico Risk Group Classification for Predicting Survival…

J. Urology 2008;179():1354-1361

Find this article


#48

Busch, J
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience

BJU Int 2012;110(11):E985-90

Find this article


#3

Critz, F
10 Year disease free survival rates after simultaneous irradiation fro prostate cancer with a focus on calulation and methodology

J. Urology 2004;172():2232-2338

Find this article


#157

Critz, FA
25-year disease-free survival rate after irradiation for prostate cancer calculated with the prostat specific antigen definition of recurrences used for radical prostatectomy

J Urol 2013;189(3):878-83

Find this article


#33

Crouzet, S
Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncological outcomes and morbidity in 1002 patients

Eur Urol 2013;epub Apr 30():

Find this article


#151

Cury, FL
Single-fraction high-dose-rate brachytherapy and hypofractionated exteranl beam radiation therapy in the treatment of intermediate-risk prostate cancer- long term results

IJROBP 2012;82(4):14717-23

Find this article


#32

Dattoli, M
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features

Cancer 2007;110(3):551-555

Find this article


#40

Dattoli, M
Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Irradiation and Brachytherapy

Journal of Oncology 2010;2010():Article ID 471375 6pgs.

Find this article


#38

Demanes, D J
Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation

Am J. Clinical Oncology 2009;32(4):342-347

Find this article


#4

Galalae, R
Long-term outcome by risk factors using conformal high dose brachy boost with or without Neoadjuvant androgen suppression for localized prostate cancer

IJROBP 2004;58(4):1048-1055

Find this article


#36

Galalae, R
Hypofractionated Conformal HDR Brachytherapy in Hormone Naïve Men with Localized Prostate Cancer: Is Escalation to Very High Biologically Equivalent Beneficial in All Progonstic Risk Groups?

Strahlentherapie und Onkologie 2006;181():135-141

Find this article


#163

Ganzer, R
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.

BJU Int 2013;112(3):322-9

Find this article


#25

Genebes, C
Conventional versus automated implantation of loose seeds in prostate brachytherapy: analysis of dosimetric and clinical results

IJROBP 2013;87(4):651-58

Find this article


#49

Herbert, C
Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: A population-based cohort study

Radiother Oncol 2012;103(2):228-32

Find this article


#46

Hinnen, K
Long-Term Biochemical and Survival Outcome of 921 Patients Treated with I125 Permanent Prostate Brachytherapy

IJROBP 2010;76(5):1433-1438

Find this article


#34

Ho, A
Radiation Dose Predicts for Biochemical Control in Intermediate-risk Prostaste Cancer Patients Treated with Low-dose rate Brachytherapy

IJROBP 2009;75(1):16-22

Find this article


#35

Ho, A
Radiation Dose Predicts for Biochemical Control in Intermediate-risk Prostaste Cancer Patients Treated with Low-dose rate Brachytherapy

IJROBP 2009;75(1):16-22

Find this article


#161& 168

Izard, M
Long-term outcome for prostate cancer using pseudo pulse-dosed rate brachytherapy, external beam radiotherapy, and hormones

Brachytherapy 2013;12(6):608-14

Find this article


#152

Khor, R
Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs. external beam radiation therapy alone for prostate cancer

IJROBP 2013;85(3):1679-85

Find this article


#152

Khor, R
Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs. external beam radiation therapy alone for prostate cancer

IJROBP 2013;85(3):1679-85

Find this article


#5

Klein, E
Outcomes For Intermediate Risk Prostate Cancer: Are There Advantage For Sugery, External Beam, or Brachytherapy

Urologic Oncology 2009;27():67-71

Find this article


#6

Klein, E
Outcomes For Intermediate Risk Prostate Cancer: Are There Advantage For Sugery, External Beam, or Brachytherapy

Urologic Oncology 2009;27():67-71

Find this article


#19

Klein, E
Outcomes For Intermediate Risk Prostate Cancer: Are There Advantage For Sugery, External Beam, or Brachytherapy

Urologic Oncology 2009;27():67-71

Find this article


#153

Kotecha, R
Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer

Brachytherapy 2013;12(1):44-49

Find this article


#8

Kuban, D
Long-Term Multi-Institutional Analysis of Stage T1-T2 Prostate Cancer Treated with Radiotherapy in the PSA Era

IJROBP 2003;57(4):915-928

Find this article


#7

Kupelian, P
Improved Biochemical Relapse-Free Survival With Increased Radiation Doses in Patients With Locaized Prostate Cancer: The Combined Experience of Nine Institutions in 1994 and 1995

IJROBP 2005;61(2):415-419

Find this article


#10

Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ≥72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer

IJROBP 2004;58(1):25-33

Find this article


#11

Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ≥72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer

IJROBP 2004;58(1):25-33

Find this article


#9

Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ≥72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer

IJROBP 2004;58(1):25-33

Find this article


#26

Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ≥72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer

IJROBP 2004;58(1):25-33

Find this article


#31

Lawton, C
Long-term results of an RTOG phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate

IJROBP 2012;82(5):e795-e801

Find this article


#164

Louis, AS
Oncologic outcomes following radical prostatectomy in the active surveillance era.

Can Urol Assoc J 2013;7(7,8):E475-80

Find this article


#165

Marina, O
Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients

Brachytherapy 2014;13(1):59-67

Find this article


#27

Marshall, R
Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center

Urol Oncol 2013;32(1):38e1-7

Find this article


#12

Martin, A-G
Permanent Prostate Implant Using High Activity Seeds & Inverse Planning With Fast Simulated Annealing Algorithum: A 12-Year Canadian Experience

Int. J. Rad Onc/Bio 2007;67(2):334-341

Find this article


#41

Menon, M
Biochemical Recurrence Following Robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up

Eur. Urol. 2010;58():838-46

Find this article


#14

Merrick, G
Prognostic Significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy

J. Urology 2005;66(5):1048-1053

Find this article


#13

Merrick, G
Androgen deprivation therapy dose not impact cause specific overall survival after permanent prostate brachytherapy

IJROBP 2006;65(3):669-677

Find this article


#155

Michalski, J
Clinical outcomes of patients treated with 3D conformal radaiation therapy (3D-CRT) for prostate cancer on RTOG 9406.

IJROBP 2012;83(3):e363-70

Find this article


#158

Morris, WJ
Population-based 10-year oncological outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer

Cancer 2013;119(8):1537-46

Find this article


#33

Moyad, M
STATINS, ESPECIALLY ATORVASTATIN, MAY FAVORABLY INFLUENCE CLINICAL PRESENTATION AND BIOCHEMICAL PROGRESSION-FREE SURVIVAL AFTER BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER

Urology 2005;66(6):1150-1154

Find this article


#159

Mullins, JK
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.

J Urol 2012;188(6):2205-10

Find this article


#42

Munro, NP
Outcomes for Gleason 7, intermediate risk, localized prostate cancer treated with iodine-125 monotherapy over 10 years.

Radiotherapy & Oncology 2010;96(1):34-37

Find this article


#163

Ohashi, T
Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation

Radiother & Oncol 2013;109():241-45

Find this article


#15

Phan, T
High dose rate brachytherapy as a boost for the treatment of localized prostate cancer

J. Urology 2007;177():123-127

Find this article


#160

Pollack, A
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer

J Clin Oncol 2013;31(31):3860-68

Find this article


#17

Potters, l
12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients With Clinically Localized Prostate Cancer

J. Urology 2005;173():1562-1566

Find this article


#18

Rossi, C. Jr.
Conformal proton beam radiation therapy for prostate cancer: Concepts and clinical results.

Community Oncology 2007;4():235-240

Find this article


#30

Sabolch, A
Gleason Pattern 5 is the Greatest Risk Factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation

IJROBP 2011;81(4):e351-60

Find this article


#169

Sekiguchi, A
125 Iodine monotherapy for Japanese men with low-and intermediate-risk prostate cancer: outcomes after 5-years of follow-up.

J Radiat Res. 2014;55(2):328-33

Find this article


#150

Sooriakumaran, P
Biochemical Recurrence After Robot-assisted Radical Prostatectomy in a European Single-centre Cohort with a Minimum Follow-up Time of 5 Years

Eur Urol 2012;62(5):768-74

Find this article


#156

Spratt, DE
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer

IJROBP 2013;85(3):686-92

Find this article


#39

Stone, N.
Local control Following Permanent Prostate Brachytherapy: Effect of High Biologically Effective Dose on Biopsy Results and Oncologic Outcomes

IJROBP 2010;76(2):355-360

Find this article


#37

Taira, A
Natural History of Clinically Staged Low- and Intermediate Risk Prostate Cancear Treated With Monotherapeutic Permanent Interstitial Brachytherapy

IJROBP 2010;76(2):349-354

Find this article


#20

Thames, H
Low/ Int Increasing External Inter Beam Dose for T1-T2 High Inter Prostate Cancer: Effect on Risk Groups

Int. J. Rad Onc/Bio 2006;65(4):975-981

Find this article


#21

Thames, H
Mid/ Increasing External Beam Dose for T1-T2 Prostate Cancer: Effect on Risk Groups

Int. J. Rad Onc/Bio 2006;65(4):975-981

Find this article


#22

Thames, H
Hi/ Increasing External Beam Dose for T1-T2 Prostate Cancer: Effect on Risk Groups

Int. J. Rad Onc/Bio 2006;65(4):975-981

Find this article


#19

Thüroff, S
Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years

J Urol 2013;190(2):702-10

Find this article


#167

Tran, A
Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial Brachytherapy monotherapy

Radiotherapy & Oncol 2013;109(2):235-40

Find this article


#43

Vassil, AD
Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation, or permanent seed implantation

Urology 2010;76(5):1251-57

Find this article


#44

Vassil, AD
Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation, or permanent seed implantation

Urology 2010;76(5):1251-57

Find this article


#45

Vassil, AD
Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation, or permanent seed implantation

Urology 2010;76(5):1251-57

Find this article


#154

Vora, S
Nine-year outcome and toxicity in patients treated with IMRT for localized prostate cancer

J Urol 2013;In Press(02/06/2013 00:00:00):

Find this article


#29

Zelefsky, M
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation

IJROBP 2007;67(2):327-333

Find this article


#28

Zelefsky, M
Long Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate Cancer

J. Urology 2006;176():1415-1419

Find this article


#33

Zumsteg, Z
(Fav. Risk) A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy

Eur Urol 2013;64(6):895-902

Find this article


#33

Zumsteg, Z
(Unfav. Risk) A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy

Eur Urol 2013;64(6):895-902

Find this article


#32

Zumsteg, Z
(+ ADT)Short-term androgen-deprivation therapy improves prostate cancer-specific mortality on intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy

IJROBP 2013;85(4):1012-7

Find this article


#32

Zumsteg, Z
(-ADT)Short-term androgen-deprivation therapy improves prostate cancer-specific mortality on intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy

IJROBP 2013;85(4):1012-7

Find this article